SERACARE TO DISTRIBUTE GRIFOLS' HUMAN SERUM ALBUMIN IN U.S.SeraCare Life Sciences, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : SRLS SRLS Stimulated Raman Loss Spectroscopy ), Oceanside, Calif., a manufacturer and distributor of plasma-based diagnostic and therapeutic products and proteins for the biotech industry, has been named distributor of Grifols' Human Serum Albumin serum albumin n. See seralbumin. (HSA HSA Health Savings Account (US) HSA Human Serum Albumin HSA Human Services Agency (Nevada) HSA Health Services Agency HSA Health and Safety Authority (Ireland) ) product for biotechnology and pharmaceutical companies in the United States. The HSA product, manufactured by Grifols, is now approved by both U.S. and European regulatory bodies for its therapeutic use and is approved to be used in the production of some pharmaceutical products and vaccines, enabling the company's customers to distribute worldwide products made with Grifols' HSA. Barry Plost, SeraCare Life Sciences' chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. commented, "Securing the U.S. distribution for Grifols' HSA enables us to supply our biotechnology and pharmaceutical customers with a high-quality product that will make their vaccine and pharmaceutical product manufacturing efforts more efficient and cost effective. A key competitive benefit of this high-quality, multiapplication product is that our customers will now be able to purchase and inventory only one form of HSA approved for use in products to be distributed to countries in North America, South America, Europe and Asia. In addition, Grifols' HSA comes with the added value of complete dossier support which facilitates the final product registration process. From a corporate perspective, this distribution relationship represents a new and unique growth opportunity for SeraCare Life Sciences which we believe should expand our marketplace, competitive product offerings and marketing reach." About the Grifols Group: Probitas Pharma (formerly Grupo Grifols) a privately held corporation Noun 1. privately held corporation - a corporation owned by a few people; shares have no public market close corporation, closed corporation, private corporation headquartered in Barcelona, Spain was founded in 1940. Initially, its primary focus was the collection of whole blood, however the company evolved rapidly into one of the leading fractionators of plasma derived blood products. Today, in addition to fractionation fractionation /frac·tion·a·tion/ (frak?shun-a´shun) 1. in radiology, division of the total dose of radiation into small doses administered at intervals. 2. , the company's primary areas of business are bioscience, pharma-medical delivery and diagnostics. The company's fractionation facility located in Parets del Valles (Barcelona) is one of the world's most modern fractionation facilities and is approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . Probitas Pharma's diagnostic division has started marketing instrumentation worldwide that will be used to test for autoimmune diseases utilizing the ELISA ELISA (e-li´sah) Enzyme-Linked Immuno-Sorbent Assay; any enzyme immunoassay using an enzyme-labeled immunoreactant and an immunosorbent. ELISA n. method. The company currently markets its products in Europe, Latin America and the United States and is expanding its presence in the Asian markets. For additional information about the Grifols Group please visit the company's web site at www.grifols.com. About SeraCare Life Sciences: SeraCare Life Sciences, Inc. is a manufacturer of human and animal-based diagnostic products and an exclusive distributor of therapeutic products and proteins to leading biotech and health care companies worldwide. Its offerings include plasma based therapeutic products, diagnostic products and reagents, cell culture products, and specialty plasmas. Based in Oceanside, California, SeraCare Life Sciences was spun-off to the public by SeraCare, Inc. in September 2001 as part of SeraCare, Inc.'s acquisition by Instituto Grifols, S.A. For additional information, visit http://www.seracare.net. or 310/772-7777. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion